Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €18.98 | - | - |
| Novavax Inc. | 5 | 1 | 1 | 1 | €10.79 | €22.91 | 112.326% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €103.50 | €112.40 | 8.597% |
| Neurocrine Bioscience | 40 | 0 | 10 | 0 | €140.30 | €149.47 | 6.537% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.10 | €2.40 | 117.391% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.15 | - | - |
| Myriad Genetics | 4 | 3 | 0 | 0 | €25.20 | €22.15 | -12.113% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Molina Healthcare | 16 | 1 | 4 | 0 | €321.50 | €373.52 | 16.180% |
| Merit Medical Systems | 22 | 0 | 2 | 0 | €78.00 | €88.37 | 13.289% |
| Merck KGaA | 4 | 2 | 1 | 1 | €163.80 | €172.00 | 5.006% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €105.60 | €125.72 | 19.052% |
| Medpace Holdings Inc | 16 | 0 | 5 | 0 | €345.50 | €418.12 | 21.020% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €99.80 | €147.62 | 47.912% |
| MannKind Corp. | 9 | 0 | 0 | 0 | €4.88 | €6.43 | 31.855% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €252.20 | €315.00 | 24.901% |
| MacroGenics Inc. | 14 | 0 | 3 | 0 | €3.50 | €11.55 | 229.558% |
| LivaNova plc | 12 | 0 | 2 | 0 | €45.00 | €66.49 | 47.760% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.92 | €4.00 | 36.986% |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.31 | €2.78 | 112.565% |
| Lexicon Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €1.55 | €9.17 | 490.380% |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €79.50 | €73.50 | -7.547% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €89.50 | - | - |